TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Year-over-year operating income growth rate
Percentile
P100
Near historical high
vs 2Y Ago
2.6x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 35.61% |
| Q3 2025 | 4.14% |
| Q2 2025 | -6.63% |
| Q1 2025 | 1.26% |
| Q4 2024 | -12.54% |
| Q3 2024 | 4.37% |
| Q2 2024 | -8.74% |
| Q1 2024 | -46.90% |
| Q4 2023 | 13.70% |
| Q3 2023 | -0.56% |
| Q2 2023 | -8.21% |
| Q1 2023 | -21.95% |
| Q4 2022 | -12.49% |
| Q3 2022 | -8.74% |
| Q2 2022 | 5.67% |
| Q1 2022 | -13.81% |
| Q4 2021 | 10.35% |
| Q3 2021 | -48.35% |
| Q2 2021 | -34.87% |
| Q1 2021 | -1.38% |
| Q4 2020 | -8.91% |
| Q3 2020 | -27.69% |
| Q2 2020 | 0.35% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |